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Abstract
Background: Accumulating evidence suggests that exercise is effective in treating many of the acute and chronic
side effects of anti-cancer therapy. A recent meta-analysis supported the use of exercise to prevent or treat fatigue
and lymphoedema and to improve functional status in breast cancer patients.
Patients and methods: This trial was intended as a controlled, prospective feasibility study evaluating the impact
of physical exercise (PE) in cancer patients during and after treatment with radio- and chemotherapy. Inclusion
criteria were previous or ongoing treatment for cancer, motivation for PE of 0.5-1hour duration at least twice
weekly for at least 3 months. Continuation of PE was encouraged thereafter. Every three months the following
endpoints were assessed: Peak oxygen consumption as measured by supervised cardiopulmonary exercise test,
body composition and quality of life.
Results: A total of 45 patients were included with a median age of 49 years. Forty were female and five male.
Cancer types were: Breast cancer (n = 30/67 %), gastrointestinal cancer (n = 5/12 %), other types (n = 10/22 %).
Thirty-eight (84 %) of the patients were included during curative treatment of their disease. Seven (16 %) were
considered palliative. Adherence to the PE-programme longer than 6 months was noted for 41/45 (91 %) of the
patients. Intensity of PE was thrice weekly in 32/45 (71 %), twice weekly in 11/45 (24 %). Two of 45 patients (5 %)
had no PE. Mean peak oxygen consumption increased from 18.8 ± 5.6 ml/min/kg to 20.5 ± 3 ml/min/kg and
19.9 ± 4.7 ml/min/kg at 3 months (p = 0.005) and 12 months (p = 0.003), respectively.
Median fat mass decreased from 30.7 ± 15 kg to 28.9 ± 15 kg and 29.5 ± 13 kg at 3 months (p = 0.001) and
12 months (p = 0.017), respectively. Global health status scores increased from a median baseline value of
54.9 ± 16.3 to 66.4 ± 14 % and 68.0 ± 20.3 % at 3 months (p = 0.001) and 12 months (p = 0.002), respectively.
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Conclusion: This exercise programme in cancer patients with 2–3 weekly supervised sessions over three
months was well feasible and demonstrated measurable improvement of oxygen consumption, body
composition and quality of life. In addition, a 90 %-adherence rate to the PE-programme beyond 6 months
was encouraging. Further randomized prospective data in a larger patient population will be collected
comparing the impact of two versus four months supervision.
Keywords: Cancer patients, Exercise intervention, Physical exercise, Quality of life, Peak oxygen consumption,
Body composition
Background
Given data from a recent meta-analysis of physical ex-
ercise (PE) that indicated a high efficacy in preventing
cancer-related fatigue and improving quality of life [1],
aerobic supervised PE seems an increasingly fascinating
tool. This may prove to be of particular value for patients
during and shortly after completion of their cancer treat-
ment since fatigue is usually reported by up to 30–60 % of
cancer patients during treatment and up to 25–30 % still
complain of fatigue years after treatment [2]. Interestingly,
cancer-related fatigue and psychological distress have been
identified as predictors for recurrence and survival in
breast cancer patients [3].
In addition, PE-programs have been gaining increasing
attention even in patients with advanced disease during
palliative treatment [4, 5]. Results from these trials indi-
cated a significant increase in muscle strength and aerobic
functional fitness as well as improvements in quality of life
and social and physical role functioning [4].
When starting a PE-program several issues may need
attention including patient selection, patient motiv-
ation, and intensity of the aerobic exercise. Of special
interest is the selection of the appropriate endpoint of a
given study.
This trial was intended as a controlled, prospective
feasibility study evaluating the impact of PE in an unse-
lected population of cancer patients during and after
treatment. Every three months the endpoints peak oxy-
gen consumption, body composition and quality of life
were assessed.
Patients and methods
This trial was intended as a controlled, prospective
feasibility study evaluating the impact of physical exer-
cise (PE) in cancer patients during and after treatment
with radio- and chemotherapy. In addition, data on mo-
tivation and adherence to a regular PE-programme dur-
ing a 12-month period should be collected. This trial
was approved by the Ethics Committee of the Medical
Faculty of the University of Erlangen-Nürnberg under
the registration number 4448. All participants provided
written, signed informed consent.
Participant recruitment
Multiple strategies were used to recruit participants.
Patients were primarily recruited through the depart-
ments of Radiation Oncology and Gynaecology, were
provided with an information sheet by their treating
nurses and doctors during routine appointments. In
case of an expression of interest by the patient the
study nurse explained the study in further detail and
checked for eligibility criteria (n = 52, Fig. 1). Inclu-
sion criteria were: Age > 18 years, previous or ongoing
treatment for cancer, motivation for PE of 0.5–1 hour
duration at least twice weekly under supervision of
the study nurse for a minimum time of 3 months.
Continuation of PE was strongly encouraged there-
after. Exclusion criteria were: body-mass index (BMI)
< 18 kg/m2 with no upper limit; performing >60 min/
week of moderate vigorous intensity exercise during
the previous 6 weeks, and major comorbidities, (e.g.
unstable angina, seizures, congestive heart failure of
NYHA grade 3–4, uncontrolled infections).
Exercise intervention
Prior to initiation of the exercise program individual
data on oxygen-consumption, optimum aerobic heart-
rate and ECG-recordings were performed. Thereafter
three weekly individually tailored exercise sessions be-
tween 30 and 60 min were done with gradually increas-
ing intensity. During the first three months all sessions
were performed at a private gymnasium in small groups
under the supervision of the study nurse. The following
devices were used depending on individual preferences:
Sitzfahrrad Lotus R, Crosstrainer ELYX 3, Coach E
Rowing Machine (all manufactured by Kettler, Ense-Parsit,
Germany), Treadmill Horizon Ti 52 (Horizon Fitness, New
Jersey, USA). All exercise was performed under optimum
heart rate as determined by spiroergometry prior to ini-
tiation of the program. After that participants were en-
couraged to continue the exercise program at home
and adherence was monitored through participant-
completed exercise diaries, regular follow-up visits and/
or phone calls.
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Data collection
Demographic characteristics and medical history were
obtained from the medical records and by the use of a
nurse-driven questionnaire at baseline. All other measures
were taken by trained technicians of Department of
Cardiology and by the study nurse. Participant recorded
any adverse event (bodily or psychological complaints)
in their daily exercise diaries regardless of the cause of
complaint.
At baseline and every three months peak oxygen con-
sumption (VO2max) was quantified by an incremental su-
pervised cardiopulmonary exercise test (CPET). After a
1-min warm-up at 20 W, cycling workload was increased
every minute by a predetermined 10, 15, or 20 W until
exhaustion or symptom limitation (dyspnea/fatigue). In
addition, maximum power (Pmax), and heart rate (HR) at
the ventilatory threshold (VT) were determined. According
to CPET-guidelines for clinical and cancer popula-
tions, a 12-lead electrocardiographic monitoring (VIASYS
Healthcare Medizintechnik, Neustadt/A., Germany)
was performed during the exercise test. All tests were
performed on an electronically braked cycle ergometer
(Ergoline ergoselect 200, ergoline, Bitz, Germany) with
breath-by-breath expired gas analysis (Erich Jaeger,
Höchberg, Germany). The analysis of expired air allowed
the determination of oxygen uptake, carbone dioxide
production (VCO2), ventilation (VE), and respiratory
exchange ratio (RER;VCO2/VO2) during rest and exercise.
Maximal oxygen uptake was the highest oxygen uptake
during exercise.
Body composition including total body water, fat-free
mass, lean body mass, fat mass, body cell mass, extracellu-
lar mass, body mass index and phase angle was determined
in triplicate by bioelectrical impedance spectroscopy
(BIA 2000 S, Medical Health Care GmbH, Karlsruhe)
at baseline and monthly during the first three months
and every three months thereafter.
Quality of life data were collected using the 30-item
Quality of Life Questionaire C-30 [6] as provided by the
European Organisation for Research and Treatment of
Cancer database.
All statistical data were entered onto PASW statistical
software (Version 18; SPSS inc, Chicago, IL), and
expressed as mean and median values with standard
Fig. 1 Participant flow diagram
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deviation. The analysis assessed the intervention effect
at 3 and 12 months as compared to the values at baseline
based on intention-to-treat principles. Baseline-values
for all parameters were compared with those at 3 and
12 months using a t-test.
The amount of missing data at each assessment was
minimal: Two patients died of tumor progression at 9
and 11 months after inclusion in the study, another four
patients had incomplete follow-up with missing 12-
month-data (Fig. 1). A sample size of 40 patients with a
drop-out rate of 5 % was calculated as sufficient to gen-
erate early data on feasibility and a possible hypothesis
for later investigations
The mean changes in outcomes from baseline to
month 3 and 12 were computed by the paired student
t-test. A normal distribution was noted for all outcomes.
Statistical tests were two-sided and p <0.05 was con-
sidered statistically significant (Null hypothesis: mean
difference is zero and alternative hypothesis: mean
difference greater than zero).
Results
Recruitment and retention
Of the 52 patients that initially expressed interest, seven
did not meet the inclusion criteria: one patient with a
critically low body mass index below 18 kg/m2 and an-
other six patients that had regular physical exercise of at
least 3 h per week. A total of 45 patients provided in-
formed consent and were scheduled for the programme
between 06/2011 and 11/2014 (ITT population). Two
patients never received the intervention. Reasons were
repeated surgery (n = 1) and no motivation (n = 1) and
were therefore excluded for further follow-up. Figure 1
displays the participant flow diagram. A total of 43 pa-
tients received the intervention and some follow-up
data, of whom four remained with incomplete follow-up
data (two patients died during the 12-month- period,
and four patients remained with incomplete follow-up of
<12 months).
As for the ITT population of 45 patients, patient char-
acteristics are given in Table 1. Median age was 49 years
(range, 35–74 years). Forty out of 45 patients (89 %) were
female and five (11 %) male. Distribution of cancer types
was: Breast cancer (n = 30/67 %), gastrointestinal cancer
(n = 5/12 %), other types (n = 10/22 %). Thirty-eight
(84 %) of the patients were included during curative treat-
ment of their disease. Seven (16 %) were considered pallia-
tive. Ongoing radiation and/or chemotherapy was noted
for 37 (82 %) of the patients whereas eight (18 %) of the
patients had previous cancer treatments.
Adherence
Adherence to the PE-programme for longer than 3 and
6 months was noted for 42/45 (93 %) and 41/45 (91 %)
of the patients, respectively. Physical exercise of at least
12 months was completed by 37/45 (82 %) of the pa-
tients. Intensity of PE was thrice weekly in 32/45 (71 %),
twice weekly in 11/45 (24 %).
Adverse events
Adverse events attributable to the study included the ex-
acerbation of lumbar spine complaints in one patient,
which was later diagnosed as progression of her lymph-
oma, and anal discomfort with bloody discharge in an-
other patient previously treated for anal cancer. These two
patients were advised to discontinue the PE-programme
and received treatment for their underlying problems.
Primary outcomes
Data for body mass composition at baseline and after
1,2,3,6 and 12 months following physical exercise are
displayed (Additional file 1: Table S1). As compared
with baseline, median body mass index decreased
from 27.4 ± 7.2 kg/m2 to 25.9 ± 7.0 kg/m2 and 26.9 ±
6.7 kg/m2 at 3 (p = 0.001) and 12 months (p = 0.015), re-
spectively. Similar data with decreasing values during the
first three months after the intervention were seen for the
total fat mass (Additional file 1: Figure S1). Median
fat mass decreased from 30.7 ± 15 kg to 28.9 ± 15 kg
and 29.5 ± 13 kg at 3 months (p = 0.001) and 12 months
(p = 0.017), respectively. No difference for the body
composition-endpoints were detected when comparing
the data between 3 and 12 months (p = 0.8).
Table 1 Patients characteristics
Total number of pts 45 (100 %)
Age (years) Median (Range) 49 (35–74)
Gender Female 40 (89 %)
Male 5 (11 %)
Tumor type Breast Cancer 30 (67 %)
Colorectal Cancer 5 (11 %)
Endometrial Cancer 3 (7 %)
Brain Tumor 3 (7 %)
Lymphoma 2 (4 %)
Other 2 (4 %)
Intent of treatment Curative 38 (84 %)
Palliative 7 (16 %)
Type of treatment Ongoing radiation/chemotherapy 37 (82 %)
Previous treatment 8 (18 %)
Adherence >3 Months 42 (93 %)
>6 Months 41 (91 %)
Physical exercise
sessions (weekly)
Thrice 32 (71 %)
Twice 11 (24 %)
Nil 2 (5 %)
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Mean peak oxygen consumption increased from
18.8 ± 6 ml/min/kg at baseline to 20.5 ± 5 ml/min/kg and
19.9 ± 5 ml/min/kg at 3 and 12 months, respectively
(Fig. 2, Additional file 1: Table S2). The difference between
values at baseline vs 3 months (p = 0.005) and 12 months
(p = 0.003) was statistically significant.
Quality of life data on functional scales and symptom
scales for all evaluable patients at baseline and at 3 and
12 months following continuous physical exercise are
displayed in Fig. 3 and Additional file 1: Figure S2,
respectively, as well as in Additional file 1: Tables S3
and S4. Global health status scores increased from a
median baseline value of 54.9 ± 16.3 % to 66.4 ± 14 % and
68.0 ± 20.3 % at 3 (p < 0.001) and 12 months (p = 0.002),
respectively (Additional file 1: Figure S3).
Subgroup analysis
For the endpoint BMI and body fat mass a significant
impact was seen comparing patients ≤ 50 years to those
of older age. Following aerobic physical exercise BMI de-
creased by 1.3 ± 1.8 kg/m2 only in the group of younger
patients at 3 months whereas in older patients the
change was only −0.17 ± 1.3 kg/m2. This difference
reached statistical significance (p = 0.03). This difference
remained stable at 12 months follow-up (p = 0.05)
(Additional file 1: Table S5). Changes in body fat mass
compared very nicely with BMI-data: Younger patients
reached a loss in body fat mass of 2.9 ± 3.5 kg and 3.0 ±
5 kg at 3 and 12 months, as compared to older patients
(−0.8 kg and −0.4 kg, p = 0.04 and 0.07), respectively
(Additional file 1: Table S6). No other factors of significant
influence on body mass composition were identified
including tumor type (breast cancer vs. others), gender,
and treatment intent (palliative with progressive disease
vs. curative).
Possible confounders for the endpoints peak oxygen
consumption and global health score were also con-
templated. Neither age nor gender turned out to have
an impact on these endpoints. However, in the sub-
group of breast cancer patients VO2max increased by
164 ± 216 ml/min as compared to other patients with
8.9 ± 344 ml/min but did not reach statistical signifi-
cance (p = 0.11) at 3 months. Comparing the group of
curative (n = 30) vs. palliative patients (n = 6), a sig-
nificant difference in the increase of VO2max was de-
tected (177 ml/min vs. −187 ml/min, p = 0.001) at
3 months. At 12 months this difference was no longer
seen since only two patients remained for analysis
(Additional file 1: Table S7). Comparison of global
health score revealed better results for breast cancer
patients vs. other patients with an increase of 16.7 ±
17.4 % and 18.7 ± 20.2 % vs. 0.7 ± 16.5 % and −1.7 ±
25.4 % at 3 (p = 0.012) and 12 months (p = 0.017), re-
spectively (Additional file 1: Table S8).
Discussion
This prospective trial attempted a supervised exercise
intervention in cancer patients during radiation and
chemotherapy. It has been the primary intention of this
study to provide useful patient data including improve-
ments in oxygen consumption, quality of life and body
Fig. 2 Peak oxygen consumption among 36 cancer patients (a) at
baseline and after 3 and 12 months (b) during continuous physical
exercise
Fig. 3 Quality of life data on functional scales for 37 cancer patients
at baseline and at 3 and 12 months following continuous
physical exercise
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composition to inform effect size estimation and guide
for a possible hypothesis in future large-scale trials.
The first and most important step seemed to motivate
patients for a possible participation in the PE-trial. Mo-
tivation and preferences for exercise programmes in pa-
tients with lung cancer have recently been reported [7].
Among a total of 60 patients a total of 63 % indicated
that they had the motivation to exercise. Significant
factors associated with motivation to exercise were:
being a non-smoker, having a past exercise history
prior to diagnosis and absence of COPD. In our ex-
perience, the initial patient information by the attend-
ing physician and the study nurse was of critical
importance. We offered a supervised exercise program
that would provide several individual benefits including
less treatment-related side-effects, better quality of life,
and improved social well-being.
A second important step is to motivate patients for
continuous adherence to the exercise program during
the study period. Rates of adherence were reported in
the literature varying widely between 83 % [2] for an 18-
week exercise intervention during breast cancer treat-
ment, and 46 % for resistance training in another trial
[8]. Recently, web-based programmes that target changes
in exercise and dietary behaviors have been reported as
being particularly useful [9] to maintain adherence.
Among our patients, monthly evaluation of body
composition, dietary consultation when requested and
discussion of the individual results proved particularly
useful. For patients not willing to participate in supervised
high-intensity programmes, obviously home-based
low-intensity physical activity programmes were identified
as viable alternative being almost as effective in breast
cancer patients [10].
Among the numerous outcome measures of random-
ized supervised exercise trials in cancer patients, cancer-
related fatigue (CRF) is clearly one of the best documented
endpoints [11, 12]. A recent meta-analysis identified nine
high-quality studies that had included a total of 1156
patients and compared the impact of supervised aerobic
exercise of various intensity levels to usual care [1].
Exercise interventions had a mean length of 21.4 weeks
(SD 15.8) with a mean duration of 44 min (SD 15.2) and
an average of 2.5 (SD 0.7) sessions per week. Cancer-
related fatigue was significantly improved in the interven-
tion group with a standardized mean difference of −0.51
(95 % CI, −0-81 to −0.21). With a length of 52 weeks, a
usual duration of one hour and three sessions per week,
exercise interventions in our trial were at the upper limit
of the data provided by the metaanalysis.
Another well documented outcome measure in trials
evaluating a possible impact of aerobic exercise in cancer
patients is the peak oxygen consumption (VO2 peak) dur-
ing cardiopulmonary exercise testing (CPET). We have
demonstrated in this study that VO2 peak among 36 can-
cer patients increased by 1.7 ml/min/kg at 3 months and
1.1 ml/min/kg at 12 months, respectively, following a su-
pervised aerobic exercise programme of two or three
weekly sessions over a time period of one year. This in-
crease seems particularly remarkable given the fact that
over 80 % of the patients had an ongoing chemotherapy
and/or radiation during the study period. Randomized
trials from the literature that compared patients of inter-
ventional groups to those of control groups usually re-
ported a decrease of VO2 peak in the control groups
between 1.02 ml/min/kg [13], and 1.31 ml/min/kg [8].
Courneya et al. [14] observed a difference in VO2 peak in
patients belonging to the interventional group vs the con-
trol group of only 0.98 ml/min/kg. This difference was ex-
plained by the stabilization of VO2 peak in the
interventional group and a decreased value in the control
group. Subgroup analysis according to our data revealed a
trend for a possible benefit in terms of oxygen consump-
tion particularly among breast cancer patients (p = 0.11)
and patient treated with curative intent (p = 0.001).
Another possible outcome measure for the effects of
aerobic exercise in cancer patients may be represented
by improvements in body composition. This pilot study
was able to demonstrate a significant reduction in body
mass index and body fat mass among 37 cancer patients.
As compared with baseline, median body mass index
decreased from 27.4 ± 7.2 kg/m2 to 25.9 ± 7.0 kg/m2
and 26.9 ± 6.7 kg/m2 at 3 (p = 0.001) and 12 months
(p = 0.015), respectively. Starting from a median value of
30.7 ± 15.4 kg for body fat mass, the patients reached 28.9
± 15 kg at 3 months and 29.5 ± 13 kg at 12 months, re-
spectively. Subgroup analysis from our data showed that
mean BMI decreased by 1.3 ± 1.8 kg/m2 only in the group
of younger patients at 3 months whereas in older patients
the change was only −0.17 ± 1.3 kg/m2. This difference
reached statistical significance (p = 0.03).
Similar data have been presented by van den Dungen
et al. [4] and O’Neill et al. [15]. This latter group ran-
domized a total of 94 prostate cancer patients receiving
androgen deprivation therapy to an interventional arm
that consisted of dietary and physical activity recommen-
dation versus usual care. The primary outcome of inter-
est was body composition. The interventional group had
a significant (p < 0.001) reduction in weight, body mass
index and percentage fat mass compared to the control
group at six months; the between-group differences were
−3.3 kg, −1.1 kg/m2 and −2.1 %, respectively.
Conclusion
In conclusion, an aerobic exercise programme in cancer
patients with 2–3 weekly supervised sessions over
12 months was well feasible and demonstrated measurable
improvement of oxygen consumption, body composition
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and quality of life. Further randomized prospective data in
a larger patient population preferring breast cancer pa-
tients will be collected comparing the impact of one ver-
sus three months supervision.
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